Pharmacological targeting of TNS3 with histone deacetylase inhibitor as a therapeutic strategy in esophageal squamous cell carcinoma

被引：5
|
作者：
Shi, Yang [1 ,2 ]
Xiang, Zheng [4 ]
Yang, Huiyu [1 ,2 ]
Khan, Suliman [5 ]
Li, Ruizhe [3 ]
Zhou, Siran [1 ,2 ]
Ullah, Saif [1 ,2 ]
Zhang, Jiyu [1 ,2 ]
Liu, Bingrong [1 ,2 ]
机构：
[1] Zhengzhou Univ, Dept Gastroenterol, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China
[2] Zhengzhou Univ, State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou 450052, Peoples R China
[3] Zhengzhou Univ, Affiliated Hosp 1, Dept Pathol, Zhengzhou 450052, Peoples R China
[4] Zhengzhou Univ, Henan Univ, Henan Prov Peoples Hosp, Dept Pathol,Peoples Hosp, Zhengzhou 450003, Peoples R China
[5] Zhengzhou Univ, Affiliated Hosp 2, Dept Cerebrovasc Dis, Zhengzhou 450000, Peoples R China
来源：
AGING-US | 2021年 / 13卷 / 11期
基金：
中国国家自然科学基金;
关键词：
histone deacetylase inhibitors; LMK-235; esophageal squamous cell carcinoma; tensin-3; histone acetylation; SRC FAMILY KINASES; HDAC INHIBITORS; PROTEIN; EPIGENETICS; COMBINATION; EXPRESSION; PACKAGE;
D O I：
10.18632/aging.203091
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Histone acetylation which regulates about 2-10% of genes has been demonstrated to be involved in tumorigenesis of esophageal squamous cell carcinoma (ESCC). In this study, we investigated the treatment response of ESCC to selective histone deacetylase inhibitor (HDACi) LMK-235 and potential biomarker predicting the treatment sensitivity. We identified tensin-3 (TNS3) which was highly over-expressed in ESCC as one of the down-regulated genes in response to LMK-235 treatment. TNS3 was found positively correlated with the tumor malignancy and poor prognosis in the patients. Silencing TNS3 significantly inhibited ESCC cell proliferation both in vitro and in vivo, sensitizing the treatment response to LMK-235. Our findings provide an insight into understanding the oncogenic role of TNS3 in ESCC and its clinical application for HDAC targeted therapy of ESCC.
引用
收藏
页码：15336 / 15352
页数：17
相关论文
共 50 条
  • [41] The Prognostic Significance of Histone Demethylase UTX in Esophageal Squamous Cell Carcinoma
    Li, Shau-Hsuan
    Lu, Hung-I
    Huang, Wan-Ting
    Tien, Wan-Yu
    Lan, Ya-Chun
    Lin, Wei-Che
    Tsai, Hsin-Ting
    Chen, Chang-Han
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (01)
  • [42] Targeting epigenetic modulation of cholesterol synthesis as a therapeutic strategy for head and neck squamous cell carcinoma
    Xing Xu
    Jun Chen
    Yan Li
    Xiaojie Yang
    Qing Wang
    Yanjun Wen
    Ming Yan
    Jianjun Zhang
    Qin Xu
    Yan Wei
    Wantao Chen
    Xu Wang
    Cell Death & Disease, 12
  • [43] Targeting epigenetic modulation of cholesterol synthesis as a therapeutic strategy for head and neck squamous cell carcinoma
    Xu, Xing
    Chen, Jun
    Li, Yan
    Yang, Xiaojie
    Wang, Qing
    Wen, Yanjun
    Yan, Ming
    Zhang, Jianjun
    Xu, Qin
    Wei, Yan
    Chen, Wantao
    Wang, Xu
    CELL DEATH & DISEASE, 2021, 12 (05)
  • [44] Targeting DNA damage response as a potential therapeutic strategy for head and neck squamous cell carcinoma
    Lei, Huimin
    He, Ading
    Jiang, Yingying
    Ruan, Min
    Han, Nannan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [45] Silencing of histone deacetylase 3 suppresses the development of esophageal squamous cell carcinoma through regulation of miR-494-mediated TGIF1
    Yang Yang
    Yuan Zhang
    Zongxiang Lin
    Kai Wu
    Zhanfeng He
    Dengyan Zhu
    Jia Zhao
    Chunyang Zhang
    Yuxia Fan
    Cancer Cell International, 22
  • [46] Silencing of histone deacetylase 3 suppresses the development of esophageal squamous cell carcinoma through regulation of miR-494-mediated TGIF1
    Yang, Yang
    Zhang, Yuan
    Lin, Zongxiang
    Wu, Kai
    He, Zhanfeng
    Zhu, Dengyan
    Zhao, Jia
    Zhang, Chunyang
    Fan, Yuxia
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [47] STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma
    Zhang, Qu
    Zhang, Chi
    He, Jia
    Guo, Qing
    Hu, Desheng
    Yang, Xi
    Wang, Jinfeng
    Kang, Yahui
    She, Ruifang
    Wang, Zhongming
    Li, Defan
    Huang, Guanhong
    Ma, Zhaoming
    Mao, Weidong
    Zhou, Xiaoyi
    Xiao, Chuangying
    Sun, Xinchen
    Ma, Jianxin
    TUMOR BIOLOGY, 2015, 36 (03) : 2135 - 2142
  • [48] Exploring metabolic therapeutic targets for esophageal squamous cell carcinoma
    Inoue, Jun
    Kishikawa, Masahiro
    Asakage, Takahiro
    Inazawa, Johji
    CANCER SCIENCE, 2021, 112 : 385 - 385
  • [49] EpCAM, a Potential Therapeutic Target for Esophageal Squamous Cell Carcinoma
    Matsuda, Tatsuo
    Takeuchi, Hiroya
    Matsuda, Sachiko
    Hiraiwa, Kunihiko
    Miyasho, Taku
    Okamoto, Minoru
    Kawasako, Kazufumi
    Nakamura, Rieko
    Takahashi, Tsunehiro
    Wada, Norihito
    Kawakubo, Hirofumi
    Saikawa, Yoshiro
    Omori, Tai
    Kitagawa, Yuko
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : 356 - 364
  • [50] Roles of oncogenes in esophageal squamous cell carcinoma and their therapeutic potentials
    Xiao, Shuai
    Huang, Guo
    Zeng, Weihong
    Zhou, Jun
    Li, Yukun
    Fan, Tingyu
    Liu, Xiaomin
    Xia, Jiliang
    Zeng, Xi
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (03): : 578 - 591
12345